INDIA LIVE DESKNIFTY 50:23,140.50(+0.34%)SENSEX:73,895.74(+0.43%)
RDU Global
🇮🇳
Home/Topics/People & Leaders/Pascal Soriot
Back to Newsroom
👤Key Figure Dossier

Pascal Soriot

Curated news coverage, institutional background, regulatory filings, and investigative reporting across RDU Global.

2 Stories Indexed
Last Updated: Just Now
Verified Entity Intelligence
Global Markets & Equities 07 Oct 2026, 08:14 AM IST

AstraZeneca bets on Kendall Square R&D hub to power next phase of growth

AstraZeneca has opened a major research and development center in Cambridge’s Kendall Square, a move that underscores the drugmaker’s determination to deepen its U.S. innovation footprint and sustain growth well beyond the current decade. The company says the site, backed by more than $1 billion in investment in Massachusetts, is designed to accelerate discovery with advanced automation, robotics and a denser concentration of scientific talent.

By RDU Global Wire5 min read
Global Health & Biotech06 Oct 2026, 08:29 AM IST

AstraZeneca CEO Says Summit Drug Could Anchor Next Wave of Cancer Combinations After $2 Billion Bet

AstraZeneca Chief Executive Pascal Soriot said Summit Therapeutics’ cancer drug could become a foundation for the next generation of combination therapies, underscoring why the Anglo-Swedish drugmaker has committed about $2 billion to the biotech. The comments come as AstraZeneca and Daiichi Sankyo move to test Summit’s ivonescimab alongside Datroway, a sign that large pharmaceutical groups are racing to secure the most promising assets in oncology.

5 min readRead →

👤 About this Entity

Political leaders, ministers, corporate executives, judges, athletes and creators. All news mentioning this entity is automatically verified and aggregated into this live intelligence dossier.

Co-Occurring Entities

Entities frequently referenced alongside Pascal Soriot: